Characteristic | n | % |
Total number of patients | 67 | 100 |
Histology | ||
Endometrioid | 52 | 77.6 |
G1 | 31 | 46.3 |
G2 | 18 | 26.9 |
G3 | 3 | 4.5 |
Nonendometrioid | ||
Mixed | 4 | 6.0 |
Serous | 2 | 3.0 |
Squamous | 1 | 1.5 |
Carcinosarcoma | 8 | 11.9 |
FIGO stage | ||
I | 46 | 68.7 |
II | 8 | 11.9 |
III | 7 | 10.4 |
IV | 6 | 9.0 |
Treatment | ||
Surgery | 32 | 47.8 |
Surgery + chemotherapy | 35 | 52.2 |
Lymphadenectomy | 51 | 76.1 |
Myometrial invasion ≥ 1/2 | 20 | 29.9 |
Tumor size ≥ 2 cm | 43 | 64.2 |
Presence of LVSI | 26 | 38.8 |
Presence of lymph node metastasis | 7 | 10.4 |
Tumor progression | 14 | 20.9 |
Death | 6 | 9.0 |